<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111984</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Positive assessment of drugs: 4th quarter 2012</dc:title>
<dc:description xml:lang="en">The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the last quarter of 2012, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU)</dc:description>
<dc:creator>González Alfonso, M</dc:creator>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Puerro Vicente, M</dc:creator>
<dc:creator>Prats Olivan, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en el último trimestre de 2012, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;69(1): 45-49, ene.-mar. 2013.</dc:source>
<dc:identifier>ibc-111984</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: 4. º Trimestre 2012</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d24613</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d51440</dc:subject>
<dc:type>article</dc:type>
<dc:date>201303</dc:date>
</metadata>
</record>
</ibecs-document>
